← Eichor
Study identifier: NCT03169231 Synced from ClinicalTrials.gov · July 28, 2026
● Completed

Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty

Condition: Aging Frailty  ·  Sponsor: Longeveron Inc.

PhasePhase 2
Planned participants150
Who can joinAll sexes, 70 Years to 85 Years
Healthy volunteersNo

About this study

This is a randomized, placebo-controlled, double-blind, parallel arm, multi-center Phase 2b study.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (7)

Soffer Health InstituteAventura, Florida, United States
Clinical Research of South FloridaCoral Gables, Florida, United States
Clinical Physiology AssociatesFort Myers, Florida, United States
Miami VA Healthcare SystemMiami, Florida, United States
Vista Health ResearchMiami, Florida, United States
Panax Clinical ResearchMiami Lakes, Florida, United States
Advanced Research for Health Improvement, LLCNaples, Florida, United States

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03169231